GHSR and metabolic dysfunction-associated steatotic liver disease: The decrease of UAG/AG in the circulation, combined with hypothalamic AG and its receptor GHSR-1a over-expressed, is possibly associated with hepatic lipid deposit and IR in NAFLD.